Matthew Winton Inozyme Pharma, Inc. (INZY) insider trading activity

INZY Quotes by TradingView

Matthew Winton is COO of Inozyme Pharma, Inc.. Currently has a direct ownership of 7,388 shares of INZY, which is worth approximately $6,796. The most recent transaction as insider was on Mar 31, 2025, when has been sold 2,490 shares (Common Stock) at a price of $0.77 per share, resulting in proceeds of $1,917. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.39K
50.84% 3M change
131.74% 12M change
Total Value Held $6,796

Matthew Winton Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 31 2025
BUY
Grant, award, or other acquisition
$1,917 $0.77 p/Share
2,490 Added 25.21%
7,388 Common Stock
Sep 30 2024
BUY
Grant, award, or other acquisition
$7,609 $4.45 p/Share
1,710 Added 25.88%
4,898 Common Stock
Mar 28 2024
BUY
Grant, award, or other acquisition
$10,616 $3.33 p/Share
3,188 Added 50.0%
3,188 Common Stock
MW

Matthew Winton

COO
Boston, MA

Track Institutional and Insider Activities on INZY

Follow Inozyme Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INZY shares.

Notify only if

Insider Trading

Get notified when an Inozyme Pharma, Inc. insider buys or sells INZY shares.

Notify only if

News

Receive news related to Inozyme Pharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on INZY